object
develop
valid
singlestep
accur
revers
transcriptas
mediat
isotherm
amplif
techniqu
rtlamp
rapid
identif
sar
rel
commerci
quantit
revers
transcriptas
realtim
pcr
qrtpcr
assay
allow
prompt
initi
proper
medic
care
contain
viru
spread
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
primer
show
optim
insilico
featur
subject
analyt
sensit
specif
assess
limit
detect
lod
crossreact
closelyand
relat
viral
speci
clinic
promin
bacteri
fungal
speci
order
evalu
clinic
util
rtlamp
subject
larg
number
clinic
sampl
includ
neg
posit
patient
rel
two
commerci
quantit
rtpcr
assay
report
march
case
found
countriesregion
infect
patient
among
die
world
health
organ
situat
report
latest
phylogenet
analysi
studi
design
etiolog
agent
sar
virul
natur
viru
high
rate
transmiss
warrant
robust
rapid
sensit
specif
quantit
diagnost
tool
supplement
clinic
symptom
aid
clinician
confid
rule
rule
patient
moreov
diagnost
tool
help
prevent
spread
viru
identifi
infect
case
monitor
health
statu
infect
patient
quantifi
viral
load
center
diseas
control
first
develop
quantit
revers
transcriptas
realtim
pcr
rtpcr
later
becam
gold
standard
techniqu
http
subsequ
chines
group
use
rnabas
metagenom
next
gener
sequenc
mng
diagnos
viral
rna
clinic
sampl
two
patient
howev
requir
advanc
technolog
skill
personnel
long
turnaround
time
hour
feasibl
local
referr
laboratori
therefor
colorimetr
loop
mediat
isotherm
amplif
also
known
lamp
develop
obviat
need
expens
technolog
eg
realtim
pcr
ng
well
shorten
turnaround
time
minut
howev
assay
qualit
one
also
swab
sampl
limit
number
patient
includ
test
recent
newer
gener
singl
step
rtlamp
develop
detect
sar
assay
challeng
real
clinic
sampl
obtain
posit
patient
therefor
develop
sensit
specif
rapid
rtlamp
assay
perform
challeng
extens
number
confirm
neg
patient
rel
qrtpcr
assay
approv
two
chines
food
drug
administr
qrtpcr
nmpa
altogeth
present
rapid
reliabl
diagnost
tool
potenti
could
deploy
highthroughput
screen
applic
referr
local
laboratori
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
accord
guidelin
prevent
control
analyt
sensit
specif
test
perform
lab
order
mimic
real
viral
particl
purchas
pseudotyp
assay
system
contain
part
sequenc
n
gene
e
gene
daan
gene
co
ltd
guangzhou
china
rna
pseudotyp
viru
extract
use
spin
column
viral
total
rna
extract
kit
sangon
biotech
co
ltd
shanghai
china
serial
dilut
magnitud
contain
cellml
cellml
pseudotyp
viru
perform
determin
limit
detect
lod
serial
dilut
test
perform
rnasednas
free
molecular
grade
water
sputum
sampl
collect
neg
healthi
individu
reproduc
lamp
assay
linearityr
valu
assess
separ
serial
dilut
test
three
occas
perform
duplic
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
signal
intens
time
obtain
decent
amplif
curv
record
institut
medic
mycolog
shanghai
changzheng
hospit
lamp
incub
time
set
minut
observ
limit
detect
crossreact
lamp
condit
mention
clinic
evalu
section
reaction
endpoint
time
set
way
detect
lowest
possibl
copi
number
viru
without
crossreact
clinic
sampl
obtain
patient
contain
wide
rang
inhibitor
impair
efficaci
diagnost
assay
therefor
toler
lamp
assay
assess
copyml
simul
viral
particl
mix
human
blood
mucin
adrenerg
bronchodil
tamiflu
dexamethason
adrenalin
clinic
valid
engag
two
clinic
center
name
second
affili
hospit
yuy
children
hospit
wenzhou
medic
univers
wenzhou
china
center
one
wuxi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
infecti
diseas
hospit
wuxi
china
center
two
center
use
differ
qrtnmpa
assay
gold
standard
techniqu
kit
shanghai
biogerm
medic
biotechnolog
co
ltd
nmpa
approv
number
lod
copiesml
ct
cutoff
kit
daan
gene
co
ltd
nmpa
approv
number
lod
copiesml
cut
ct
valu
use
center
one
center
two
respect
posit
patient
divid
two
group
physician
name
suspect
confirm
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
whole
workflow
studi
insilico
analysi
analyt
evalu
clinic
valid
depict
figur
nine
six
lamp
primer
system
design
evalu
insilico
six
primer
show
highest
sensit
specif
use
next
step
tabl
primarili
assay
meant
quantit
show
optim
reproduc
test
analyt
evalu
step
use
armor
viral
particl
dilut
water
r
valu
sputum
sampl
r
valu
analyt
sensit
yield
reliabl
lod
copiesml
less
minut
regardless
matrix
use
serial
dilut
figur
note
assay
could
detect
copiesml
replic
show
unstabl
amplif
therefor
consid
lod
copiesml
analyt
specif
use
wide
rang
closelyand
distantlyrel
viral
speci
promin
fungal
bacteri
speci
human
dna
moreov
analyt
evalu
includ
wide
rang
inhibitor
copi
simul
viral
particl
success
detect
minut
figur
order
evalu
perform
assay
clinic
provid
assay
respect
instruct
two
clinic
center
figur
total
patient
center
among
confirm
case
patient
center
among
patient
confirm
case
recruit
one
asymptomat
patient
test
posit
qrtpcr
ct
valu
rtlamp
categor
suspect
incharg
physician
day
later
becam
posit
four
patient
test
posit
qrtpcr
neg
rtlamp
one
patient
test
neg
qrtpcr
posit
assay
figur
supplementari
tabl
subsequ
rtlamp
assay
show
sensit
specif
neg
predict
valu
posit
predict
valu
respect
supplementari
tabl
fact
assay
could
detect
four
posit
patient
owe
use
less
rna
input
rel
qrtpcr
futur
tri
use
variou
rna
input
volum
observ
could
obtain
higher
sensit
although
rtlamp
assay
develop
quantit
could
find
pattern
associ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
time
posit
rtlamp
assay
ct
valu
report
qrtpcr
use
clinic
sampl
therefor
consid
assay
qualit
one
fact
show
analyt
valuat
alway
accompani
clinic
valid
observ
real
capabl
given
assay
result
obtain
analyt
evalu
step
alway
reflect
reallif
assay
sever
advantag
compar
qrtpcr
first
rtlamp
assay
two
time
faster
rel
qrtpcr
figur
given
optim
diagnost
featur
could
use
reliabl
screen
method
local
referr
laboratori
keep
increas
demand
suspect
patient
critic
situat
secondli
assay
need
clod
chain
could
ship
room
temperatur
figur
conclus
present
rapid
rtlamp
assay
allow
process
clinic
sampl
rel
cdc
rtpcr
indic
capac
deploy
throughput
screen
applic
local
referr
laboratori
admit
assay
quantit
aspect
qrtpcr
sensit
requir
improv
two
limit
subject
futur
investig
moreov
tri
use
simpl
fast
nucleic
acid
extract
procedur
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
figur
workflow
comparison
rtlamp
assay
rel
qrtpcr
emerg
case
outpati
inpati
rtlamp
assay
time
faster
qrtpcr
assay
ship
room
temperatur
tabl
tabl
primer
probe
success
detect
sar
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
shanghai
municip
commiss
health
famili
plan
